← Open Payments lookup

NICHOLE WISE: Open Payments

NPI 1225654189 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$601 in 26 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $601

Food & beverage: $601
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.4$112
Madrigal Pharmaceuticals4$89
Ardelyx, Inc.4$64
Janssen Biotech, Inc.1$54
Regeneron Healthcare Solutions, Inc.2$47
GENZYME CORPORATION1$39
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$38
Ipsen Biopharmaceuticals, Inc2$34
Phathom Pharmaceuticals, Inc.1$29
Celltrion USA Inc.1$22

Products named: ENTYVIO, REZDIFFRA, DUPIXENT, IBSRELA, TREMFYA, XIFAXAN, IQIRVO, VOQUEZNA.

Industry payments across IN — which companies pay providers there.